Immunotherapy for immune suppressed patients

Details for Australian Patent Application No. 2008216119 (hide)

Owner IRx Therapeutics, Inc.

Inventors Hadden, John W.

Agent Lord and Company

Pub. Number AU-A-2008216119

PCT Pub. Number WO2008/101154

Priority 11/706,946 15.02.07 US

Filing date 15 February 2008

Wipo publication date 21 August 2008

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/567 (2006.01) Investigating or analysing materials by specific methods not covered by groups - utilising isolate of tissue or organ as binding agent

Event Publications

1 October 2009 PCT application entered the National Phase

  PCT publication WO2008/101154 Priority application(s): WO2008/101154

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008216147-Methods and compositions for the disruption of biofilms

2008216116-Inductive power and data transmission system based on class D and amplitude shift keying